Data / Form D filings / NeuroLambda Therapeutics, Inc.
NeuroLambda Therapeutics, Inc.: Form D filing
NeuroLambda Therapeutics, Inc., a technology company in Cambridge, MA, filed a Form D with the SEC in 2024. The latest, on July 17, 2024, reports $3 million sold of a $5 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1 Broadway, 14th Floor, Cambridge, MA, 02142
- Phone
- (929) 375-5755
- Industry
- Other Technology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2029691
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 17, 2024 | New notice | $5,000,000 | $3,000,000 | $2,000,000 | 1 | Jun 21, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Byungchan Kim | Director | |
| Xiaowei Jin | Director | |
| Sayan Mondal | Executive Officer, Director |
Other technology companies in Massachusetts that filed recently
- Betvisors, Inc. $150,000 · Oct 30, 2026
- RESOLV TECHNOLOGY, INC. $7.2 million · Oct 30, 2026
- Cala Systems, Inc. $2.6 million · Oct 27, 2026
- Boltz, PBC $97.4 million · Oct 22, 2026
- SpartanX Technologies, Inc. $5 million · Oct 22, 2026
- Govably, Inc. $375,000 · Oct 21, 2026
Every Form D from the week of Jul 15, 2024 · All recent filings in Massachusetts · All recent Other Technology filings
Read from SEC EDGAR. Amount sold is what NeuroLambda Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.